Related Experiment Video
Updated: Dec 1, 2025

07:02
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
7.7K
Non-Coding RNAs: Uncharted Mediators of Thyroid Cancer Pathogenesis
Hossein Tabatabaeian1, Samantha Peiling Yang2,3, Yvonne Tay1,4
1Cancer Science Institute of Singapore, National University of Singapore, Singapore 117599, Singapore.
Cancers
|November 7, 2020
Summary
Non-coding RNAs (ncRNAs) are key in thyroid cancer development and treatment resistance. Understanding these molecules may lead to new diagnostic and prognostic biomarkers for better patient outcomes.
Area of Science:
- Endocrinology
- Oncology
- Molecular Biology
Background:
- Thyroid cancer is a common endocrine malignancy with significant diagnostic and treatment challenges, particularly for advanced stages.
- Poor survival rates persist for undifferentiated and metastatic thyroid cancer patients despite treatment advances.
Purpose of the Study:
- To systematically review the roles and mechanisms of non-coding RNAs (ncRNAs) in thyroid cancer.
- To explore the involvement of ncRNAs in thyroid tumorigenesis and therapeutic resistance.
- To propose ncRNAs as potential diagnostic and prognostic biomarkers for thyroid cancer.
Main Methods:
- Systematic literature review of studies on non-coding RNAs (ncRNAs) in thyroid cancer.
- Analysis of molecular mechanisms underlying ncRNA dysregulation in thyroid cancer.
- Evaluation of ncRNAs in relation to thyroid cancer development and drug response.
Main Results:
- Dysregulation of various non-coding RNAs (ncRNAs), including microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs), is implicated in thyroid cancer.
- These ncRNAs play critical roles in thyroid tumorigenesis and the development of resistance to therapies.
- Aberrant ncRNA expression correlates with treatment failure and poor prognosis in thyroid cancer patients.
Conclusions:
- Non-coding RNAs (ncRNAs) are significantly involved in the pathogenesis and progression of thyroid cancer.
- ncRNAs represent promising candidates for novel diagnostic and prognostic biomarkers in thyroid cancer management.
- Further research into ncRNA mechanisms could inform future therapeutic strategies for thyroid cancer.
Related Concept Videos
lncRNA - Long Non-coding RNAs
9.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.5K
lncRNA - Long Non-coding RNAs
3.2K
3.2K
Synthesis and Regulation of Thyroid Hormones
6.6K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
6.6K
MicroRNAs
3.5K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.5K
MicroRNAs
23.4K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.4K
Transducer Mechanism: Nuclear Receptors
2.1K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
2.1K

